# FMKLABS - Inspection Records

Source: https://www.keypedia.com/companies/fmklabs/b335f624-1732-48b8-9900-26989b236b51

> Inspection records and compliance data for FMKLABS in Corona, California. Access full analysis and detailed observations.

---

## Details

- Name: FMKLABS
- FEI Number: 3014253278
- City: Corona
- State: California
- Country Name: United States
- Address Line 1: 1690 N Delilah St
- Zip Code: 92879

## Related Documents

- [483 - FMKLABS - 2024-12-31](https://www.keypedia.com/records/483/fmklabs/8a7ea1e9-bad7-4ed9-87fb-347c8143f473) — source: FDA, date: December 31, 2024
- [WARNING_LETTER - FMKLABS - 2024-12-31](https://www.keypedia.com/records/warning_letter/fmklabs/a22c49f9-c623-482e-9843-06ca7bbed53f) — source: FDA, date: December 31, 2024
- [FDA Inspection 1257783 - FMKLABS - 2024-12-31](https://www.keypedia.com/records/fda_inspections/fmklabs/6d8511c0-096c-49e0-90f1-362217977bf5) — classification: Official Action Indicated (OAI), source: FDA, date: December 31, 2024
- [483 - FMKLABS - 2019-03-08](https://www.keypedia.com/records/483/fmklabs/107bf47e-65ad-4730-9485-d67b2e82e431) — source: FDA, date: March 8, 2019
- [FDA Inspection 1081833 - FMKLABS - 2019-03-08](https://www.keypedia.com/records/fda_inspections/fmklabs/a8c43d7f-718d-497c-83fd-b7bc2d44fed1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 8, 2019
- [FDA Inspection 1069380 - FMKLABS - 2018-10-22](https://www.keypedia.com/records/fda_inspections/fmklabs/9124f900-9a0c-4b53-985b-29c6fb5abe09) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2018

## Related Companies

- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Novartis Pharmaceuticals Corporation](https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47)
- [Kite Pharma, Inc.](https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)
- [Recipharm Monts](https://www.keypedia.com/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6)
- [Steril-Gene Life Sciences Private Ltd](https://www.keypedia.com/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec)
- [Nectar Lifesciences Limited](https://www.keypedia.com/companies/nectar-lifesciences-limited/7b5dd8c8-0a38-4956-be6f-74871597ce80)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Pharmaplast S.A.E.](https://www.keypedia.com/companies/pharmaplast-sae/69fdda1e-d63c-4bd4-b5ed-402c137267a5)
- [Celltrion Pharm, Inc.](https://www.keypedia.com/companies/celltrion-pharm-inc/481a4273-bf7e-4b37-8cd8-08b977ba576b)

## Related Officers

- [Investigator](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)
- [Pearl C. Ozuruigbo](https://www.keypedia.com/people/pearl-c-ozuruigbo/28ec383e-a602-4764-8d14-20b1049f93d7)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)